1. Home
  2. REXR vs RGEN Comparison

REXR vs RGEN Comparison

Compare REXR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rexford Industrial Realty Inc.

REXR

Rexford Industrial Realty Inc.

HOLD

Current Price

$33.60

Market Cap

9.0B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$114.89

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REXR
RGEN
Founded
2013
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
REXR
RGEN
Price
$33.60
$114.89
Analyst Decision
Hold
Buy
Analyst Count
10
11
Target Price
$41.00
$175.64
AVG Volume (30 Days)
2.3M
820.9K
Earning Date
04-23-2026
04-28-2026
Dividend Yield
5.12%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
N/A
$141,236,000.00
Revenue This Year
$0.98
$14.31
Revenue Next Year
$3.36
$14.41
P/E Ratio
$43.28
$134.70
Revenue Growth
N/A
35.10
52 Week Low
$29.68
$102.97
52 Week High
$44.38
$175.77

Technical Indicators

Market Signals
Indicator
REXR
RGEN
Relative Strength Index (RSI) 30.42 34.43
Support Level N/A $112.53
Resistance Level $37.69 $132.51
Average True Range (ATR) 0.79 4.98
MACD -0.07 0.64
Stochastic Oscillator 4.40 15.60

Price Performance

Historical Comparison
REXR
RGEN

About REXR Rexford Industrial Realty Inc.

Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: